Detalhe da pesquisa
1.
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
N Engl J Med
; 386(10): 951-963, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045226
2.
The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study.
Infection
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589747
3.
Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
Infection
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607592
4.
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
Clin Infect Dis
; 76(3): e533-e536, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723273
5.
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
Clin Infect Dis
; 76(3): e995-e1003, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879465
6.
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
Clin Infect Dis
; 77(1): 38-45, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905147
7.
Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
J Clin Microbiol
; 61(5): e0004423, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097150
8.
Correction to: Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
Infection
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668922
9.
Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
BMC Infect Dis
; 19(1): 17, 2019 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30612559
10.
Antibiotic treatment strategies for community-acquired pneumonia in adults.
N Engl J Med
; 372(14): 1312-23, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830421
11.
Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines.
Curr Opin Pulm Med
; 23(3): 204-210, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28198726
12.
Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
BMC Infect Dis
; 17(1): 52, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28068956
13.
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands.
Eur Respir J
; 46(5): 1407-16, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160871
14.
Antibiotics for Community-Acquired Pneumonia in Adults.
N Engl J Med
; 373(7): 684-6, 2015 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267636
15.
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP.
Eur Respir J
; 41(1): 123-30, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653769
16.
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
iScience
; 26(1): 105753, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507223
17.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Lancet Infect Dis
; 23(8): 901-913, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088096
18.
The Times They Are A-Changin': Time-Dependent Exposures and Time-Dependent Confounders.
Clin Infect Dis
; 65(11): 1959-1960, 2017 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020274
19.
Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?
Eur Respir J
; 50(4)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051267
20.
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
Front Immunol
; 13: 1067749, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524126